<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03623074</url>
  </required_header>
  <id_info>
    <org_study_id>CPRO-1802-001</org_study_id>
    <nct_id>NCT03623074</nct_id>
  </id_info>
  <brief_title>Control of Myopia Using Novel Spectacle Lens Designs</brief_title>
  <acronym>CYPRESS</acronym>
  <official_title>Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SightGlass Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SightGlass Vision, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical
      trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens
      design in reducing the progression of juvenile myopia.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 16, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants and parents of participants will be masked. Investigational site staff tasked with measuring key primary variables (i.e., axial length and SER) will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Axial length</measure>
    <time_frame>36 Months</time_frame>
    <description>Change in axial length from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spherical equivalent refraction</measure>
    <time_frame>36 Months</time_frame>
    <description>Change in spherical equivalent refraction from baseline</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">266</enrollment>
  <condition>Juvenile Myopia</condition>
  <arm_group>
    <arm_group_label>Test Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single vision, impact-resistant spectacle lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single vision, impact-resistant spectacle lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Arm 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single vision, impact-resistant spectacle lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Novel spectacle lens design</intervention_name>
    <description>Use of lenses may reduce the rate of progression of juvenile myopia</description>
    <arm_group_label>Test Arm 1</arm_group_label>
    <arm_group_label>Test Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectacle lenses</intervention_name>
    <description>Use of lenses may reduce the rate of progression of juvenile myopia</description>
    <arm_group_label>Test Arm 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children 6-10 years of age (day prior to 10th birthday) at time of informed
             consent/assent

          -  SER error between -0.75 and -4.50 D

          -  SER power between the two eyes must be less than or equal to 1.50 D

          -  Willingness to participate in the trial for 3 years without content lens wear

        Exclusion Criteria:

          -  Previous or current use of contact lenses

          -  Previous or current use of bifocals, progressive addition spectacles lenses

          -  Previous or current use of myopia control treatment

          -  Astigmatism worse then -1.25 DC in either eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Rappon, OD, MS, FAAO</last_name>
    <role>Study Chair</role>
    <affiliation>SightGlass Vision, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Golden Optometric Group</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sabal Eye Care</name>
      <address>
        <city>Longwood</city>
        <state>Florida</state>
        <zip>32779</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Visual Performance Center</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Associates of Northeast Louisiana (DBA Haik Humble Eye Center) Research Dept</name>
      <address>
        <city>West Monroe</city>
        <state>Louisiana</state>
        <zip>71291</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Eyecare, PC</name>
      <address>
        <city>Raytown</city>
        <state>Missouri</state>
        <zip>64133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY School of Optometry</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacco Eye Group</name>
      <address>
        <city>Vestal</city>
        <state>New York</state>
        <zip>13850</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept of Clinical Research, South Shore Eye Care, LLP</name>
      <address>
        <city>Wantagh</city>
        <state>New York</state>
        <zip>11793</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dunes Eye Consultants</name>
      <address>
        <city>Dakota Dunes</city>
        <state>South Dakota</state>
        <zip>57049</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Total Eye Care</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Houston College of Optometry</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William J Bogus, OD, FAAO</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Ocular Research &amp; Education, School of Optometry, University of Waterloo School of Optometry &amp; Vision Science</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 3, 2018</study_first_submitted>
  <study_first_submitted_qc>August 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myopia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

